Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata

Cancer Biology and Therapy

Volumn 5, Issue 1, 2006, Pages 28-33

  Liang, Minglin ^a   Wang, Hongbo ^a   Zhang, Yuan ^a   Lu, Shi ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Leiomyoma; PCNA; PDGF; PDGFR ; PDGFR ; Procollagen; RT PCR

Indexed keywords

CELL NUCLEUS ANTIGEN; COLLAGEN; COLLAGEN ALPHA1 CHAIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MENSTRUAL CYCLE; MYOMETRIUM; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; RNA EXTRACTION; UTERUS MYOMA;

EID: 32544448224     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.1.2234     Document Type: Article

References (40)

1. Cramer SF, Horiszny JA, Leppert P. Epidemiology of uterine leiomyomas. With an etiologic hypothesis. J Reprod Med 1995; 40:595-600.
2. Sozen A, Arici A. Interactions of cytokines, growth factors and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril. 2002; 78:1-12.
3. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004; 10:207-20.
4. Buttram VC Jr, Reiter RC. Uterine leiomyomata: Etiology, symptomatology, and management. Fertil Steril 1981; 36:433-45.
5. Cook JD, Walker CL. Treatment strategies for uterine leiomyoma: The role of hormonal modulation. Semin Reprod Med 2004; 22:105-11.
6. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect 2003; 111:1037-54.
7. Ohara N. Selective estrogen receptor modulator and selective progesterone receptor modulator: Therapeutic efficacy in the treatment of uterine leiomyoma. Clin Exp Obstet Gynecol 2005; 32:9-11.
8. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril 2004; 81:1062-6.
9. Yamada T, Nakago S, Karachi O, Wang J, Takekida S, Matsuo H, Maruo T. Progesterone downregulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells. Hum Reprod 2004; 19:815-21.
10. Swartz CD, Afshari CA, Yu L, Hall KE, Dixon D. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod 2005; 11:441-50.
11. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993; 69:508-17.
12. Di Lieto A, De Falco M, Pollio F, Mansueto G, Salvatore G, Somma P, Ciociola F, De Rosa G, Staibano S. Clinical response, vascular change, and angiogenesis in Gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig 2005; 12:123-8.
13. Di Lieto A, De Falco M, Mansueto G, De Rosa G, Pollio F, Staibano S. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: Evaluation of the clinical response, the immunohistochemical expression of PDGF, bEGF, and VEGF and the vascular pattern. Steroids 2005; 70:95-102,
14. (Steriods 70:95).
15. Nowak RA. Identificaion of new therapies for leiomyomas: What in vitro studies can tell us. Clin Obstet Gynecol 2001; 44:327-34.
16. Anania CA, Stewart EA, Wuade BJ, Hill JA, Mowak RA. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod 1997; 3:685-91.
17. Tsai JC, Goldman CK, Gillespie GY. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB and bEGF. J Neurosurg 1995; 82:864-73.
18. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32.
19. Barbarisi A, Petillo O, Di Lieto A, Melone MA, Margarucci S, Cannas M, Peluso G. 17-β Estradiol elicits autocrine leiomyoma cell proliferation: Evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol 2001; 186:414-24.
20. Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 2004; 15:255-73.
21. Boehm KD, Daimon M, Gorodeski IG, Sheean LA, Utian WH, Ilan J. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol Reprod Dev 1999; 27:93-101.
22. Palman C, Bowen-Pope DF, Brooks JJ. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors. Lab Invest 1992; 66:108-15.
23. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): A dancer with many partners. J Cell Sci 2003; 116:3051-60.
24. Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab 1994; 79:900-6.
25. Blyszczuk P, Czyz J, Kania G, Wagner M, Roll U, St-Onge L, Wobus AM. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci USA 2003; 100:998-1003.
26. Tsai SJ, Lin SJ, Cheng YM, Chen HM, Wing LY. Expression and functional analysis of pituitary tumor transforming growth factor-1 in uterine leiomyomas. J Clin Endocrinol Metab 2005; 90:3715-23.
27. Wang J, Ohara N, Takekida S, Xu Q, Maruo T. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells. Hum Reprod 2005; 20:1456-65.
28. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiological reviews 1999; 79:1283-1316.
29. Heldin CH. Platelet-derived growth factor - an introduction. Cytokine Growth Factor Rev 2004; 15:195-6.
30. Mendoza AE, Young R, Orkin SH, Collins T. Increased platelet-derived growth factor A-chain expression in human uterine smooth muscle cells during the physiologic hypertrophy of pregnancy. Proc Natl Acad Sci USA 1990; 87:2177-81.
31. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogaki H, Mori T. Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 1989; 160:637-41.
32. Dixon D, Flake GP, Moore AB, He H, Haseman JK, Risinger JI, Lancaster JM, Berchuck A, Barrett JC, Robboy SJ. Cell proliferation and apoptosis in human uterine leiomyomas and myometria. Virchows Arch 2002; 441:53-62.
33. Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation of cells. N Engl J Med 1980; 303:878-80.
34. Fayed YM, Tsibris JC, Langenberg PW, Robertson Jr AL. Human uterine leiomyoma cells: Binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab Invest 1989; 60:30-7.
35. Di Lieto A, De Rosa G, De Falco M, Iannotti F, Staibano S, Pollio F, Scaramellino M, Salvatore G. Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin- releasing hormone agonist treatment. Hum Pathol 2002; 33:220-4.
36. Rauk PN, Surti U, Roberts JM, Michalopoulos G. Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells. Am J Obstet Gynecol 1995; 173:571-7.
37. Martin Chaves EB, Brum IS, Stoll J, Capp E, Corleta HE. Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma. Gynecol Obstet Invest 2004; 57:210-3.
38. Gao Z, Matsuo H, Wang Y, Nakago S, Maruo T. Upregulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells. J Clin Endocrinol Metab 2001; 86:5593-9.
39. Puistola U, Risteli L, Risteli J, Kauppila A. Collagen metabolism in gynecologic patients: Changes in the concentration of the aminoterminal propeptide of type III procollagen in serum. Am J Obstet Gynecol 1990; 163:1276-81.
40. Ding L, Xu J, Luo X, Chegini N. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 2004; 89:5549-57.